Nalaganje...
Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C
The era of direct acting antivirals has revolutionised the management of chronic hepatitis C infection and improved patient outcomes. The optimal management of patients who require liver transplantation remains a matter of ongoing discussion. Treatment in the post-transplantation setting may be comp...
Shranjeno v:
| izdano v: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6011507/ https://ncbi.nlm.nih.gov/pubmed/29880625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224664 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|